Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Toyooka

Showing results (391-400 of 537) with videos related to

Pageof 54
Sort By:
Cancer Science|September 15, 2018
Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysisYuta Takahashi, Kazuhiko Shien, Shuta Tomida, et al.
Anticancer Research|November 17, 2012
MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cellsYuho Maki, Hiroaki Asano, Shinichi Toyooka, et al.
Annals of Surgical Oncology|September 1, 2023
Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine LeiomyosarcomaNaoki Matsuda, Hiromasa Yamamoto, Tomohiro Habu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2012
Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapyKazuhiko Shien, Shinichi Toyooka, Kouichi Ichimura, et al.
Cancer Research|March 9, 2005
Somatic mutations of the HER2 kinase domain in lung adenocarcinomasHisayuki Shigematsu, Takao Takahashi, Masaharu Nomura, et al.
Journal of the National Cancer Institute|December 10, 2013
Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomasHiromasa Yamamoto, Koichiro Higasa, Masakiyo Sakaguchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2018
A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non-Small Cell Lung CancerKatsuyuki Hotta, Keisuke Aoe, Toshiyuki Kozuki, et al.
Breast Cancer Research and Treatment|October 9, 2020
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatmentsMinami Hatono, Hirokuni Ikeda, Yoko Suzuki, et al.
Oncology Letters|January 2, 2016
DNA copy number gains in malignant pleural mesotheliomaMasashi Furukawa, Shinichi Toyooka, Tatsuro Hayashi, et al.
Plos One|February 6, 2014
Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancerKazuhiko Shien, Norimitsu Tanaka, Masami Watanabe, et al.
Pageof 54

Showing results (391-400 of 537) with videos related to

Sort By:
Pageof 54
Cancer Science|September 15, 2018
Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysisYuta Takahashi, Kazuhiko Shien, Shuta Tomida, et al.
Anticancer Research|November 17, 2012
MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cellsYuho Maki, Hiroaki Asano, Shinichi Toyooka, et al.
Annals of Surgical Oncology|September 1, 2023
Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from Uterine LeiomyosarcomaNaoki Matsuda, Hiromasa Yamamoto, Tomohiro Habu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2012
Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapyKazuhiko Shien, Shinichi Toyooka, Kouichi Ichimura, et al.
Cancer Research|March 9, 2005
Somatic mutations of the HER2 kinase domain in lung adenocarcinomasHisayuki Shigematsu, Takao Takahashi, Masaharu Nomura, et al.
Journal of the National Cancer Institute|December 10, 2013
Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomasHiromasa Yamamoto, Koichiro Higasa, Masakiyo Sakaguchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2018
A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non-Small Cell Lung CancerKatsuyuki Hotta, Keisuke Aoe, Toshiyuki Kozuki, et al.
Breast Cancer Research and Treatment|October 9, 2020
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatmentsMinami Hatono, Hirokuni Ikeda, Yoko Suzuki, et al.
Oncology Letters|January 2, 2016
DNA copy number gains in malignant pleural mesotheliomaMasashi Furukawa, Shinichi Toyooka, Tatsuro Hayashi, et al.
Plos One|February 6, 2014
Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancerKazuhiko Shien, Norimitsu Tanaka, Masami Watanabe, et al.
Pageof 54